Heartburn drugs increase the risk of hip fracture: AttorneyOne.com Warns the Threat from Nexium Side Effects Remains

Share Article

According to the study published on January 31st 2012, in the British Medical Journey, postmenopausal women are at a 35% increased risk of hip fractures if they regularly use proton pump inhibitors (PPIs) which includes Nexium, and that risk increases to more than 50% among women with a history of smoking. Nexium is a medication that people take to prevent on-going heartburn. According to court documents, in a lawsuit filed on September 15, 2011 (case no. 2011-55281) in Harris County, Texas District Court, two residents of Texas, Mary Mai Nguyen and Tuoc Duong claimed that the side effects of Nexium caused them to suffer fractures and bone deterioration. Now, AttorneyOne.com, a recognized authority on law, can provide helpful, proven advice and simple solutions including how to get in contact with legal council [http://www.attorneyone.com/nexium/ so anyone can easily and inexpensively deal with cases of Nexium side effects.

Nexium adverse effects threat

Nexium adverse effects threat

a possible increase in risk of fractures

The media spotlight is often a double-edged sword. No one knows this better than Mary Mai Nguyen and Tuoc Duong. And yet, gossip and rumor-mongering aside, the real story here is being overlooked according to Sean Burke of AttorneyOne.

The lawsuit filed on September 15, 2011 (case no. 2011-55281), claims that studies since 2006 revealed that PPIs interfere with the body’s ability to absorb calcium, which increases bone loss and bone fractures, and that AstraZeneca – the company manufacturing Nexium - ‘obscured, misrepresented and obfuscated” the information.

The lawsuit also says that AstraZeneca failed to adequately research the drug or warn consumers and physicians about the increased risks of bone deterioration and fracture.

On January 31st, 2012 the British Medical Journal published a study revealing that proton pump inhibitors (PPI), including Nexium, inhibits the absorption of calcium leading to the increased risk of fractures. For the study, the team collected data on approximately 80,000 postmenopausal women. In eight years, almost 900 hip fractures occurred – revealing a 35 percent increased risk for women using PPIs compared to women who didn't take the drugs.

"Our data supports the recent decision by the U.S. Food and Drug Administration to revise labeling of PPIs to incorporate concerns about a possible increase in risk of fractures with these drugs," said lead researcher Dr. Hamed Khalili, MD, from the Massachusetts General Hospital in Boston. The increased risk of fractures among women who smoked was even higher, reaching 50 percent, the team added.

AttorneyOne.com, a recognized authority on law, can provide helpful advice and simple solutions including how to get in contact with legal council so that, in case of Nexium adverse effects, someone can easily and inexpensively deal with it. As Mr. Burke, director of Media Relations for AttorneyOne.com, added, “What all this information really illustrates is that threat of severe adverse effects from Nexium remains. For that reason, our focus should squarely fall on getting the word out and assisting people in finding the right legal assistance.”

In May 2010, the FDA issued a warning regarding the increased risk of bone fracture from Nexium and other PPIs. In March 2011, the FDA stated that the risk of fracture was linked to high doses of Nexium used for a long period of time.

AttorneyOne.com has further information on Nexium lawsuits including how to get in contact with legal council.

Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. Checkout earlier legal news from us at http://www.prweb.com/releases/2012/2/prweb9156671.htm.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sean Burke
Attorney One
1-877-230-7343
Email >
Visit website